IGCS 2024: Updates and New Data

CME

Expert Insights on Key Updates and New Data Presented at the 2024 IGCS Annual Meeting Informing Treatment for Endometrial, Ovarian, and Cervical Cancers

Physicians: Maximum of 0.25 AMA PRA Category 1 Credit

Released: November 20, 2024

Expiration: May 19, 2025

Domenica Lorusso
Domenica Lorusso, MD, PhD, Prof

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

A 46-year-old patient presented with locally advanced cervical cancer. The disease involves the cervix (6 cm) and upper vagina. PET/CT is positive for various pelvic nodes and a right common iliac node.

When planning treatment that incorporates immunotherapy with concurrent chemoradiation for patients with cervical cancer, which of the following should be an important consideration?